Henoch-Schönlein purpura

Current Opinion in Rheumatology

Volumn 22, Issue 5, 2010, Pages 598-602

  Saulsbury, Frank T ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

genetic susceptibility; Henoch Sch nlein purpura; nephritis; treatment; vasculitis

Indexed keywords

CORTICOSTEROID;

ABDOMINAL PAIN; ANAPHYLACTOID PURPURA; ARTHRALGIA; CORTICOSTEROID THERAPY; DISEASE DURATION; DISEASE SEVERITY; GENETIC SUSCEPTIBILITY; HUMAN; NEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; GENETIC PREDISPOSITION; GENETICS; PROGNOSIS; PURPURA, SCHOENLEIN-HENOCH; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROGNOSIS; PURPURA, SCHOENLEIN-HENOCH; TREATMENT OUTCOME;

EID: 77955174225     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32833af608     Document Type: Review

References (38)

1. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schö nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360:1197-1202.
2. Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005; 35:143-153.
3. Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lancet 2007; 369:976-978.
4. Peru H, Soylemezoglu O, Bakkaloglu SA, et al. Henoch Schonlein purpura in childhood: clinical analysis of 245 cases over a 3-year period. Clin Rheumatol 2008; 27:1087-1092.
5. Amoroso A, Berrino M, Canale L, et al. Immunogenetics of Henoch-Schoenlein disease. Eur J Immunogenet 1997; 24:323-333.
6. Amoli MM, Thomson W, Hajeer AH, et al. HLA-DRB1 *01 association with Henoch-Schonlein purpura in patients from northwest Spain. J Rheumatol 2001; 28:1266-1270. (Pubitemid 32510497)
7. Soylemezoglu O, Peru H, Gonen S, et al. HLA-DRB1 alleles and Henoch-Schonlein purpura: susceptibility and severity of disease. J Rheumatol 2008; 35:1165-1168.
8. Peru H, Soylemezoglu O, Gonen S, et al. HLA class 1 associations in Henoch Schonlein purpura: increased and decreased frequencies. Clin Rheumatol 2008; 27:5-10.
9. Amoli MM, Thomson W, Hajeer AH, etal. HLA-B35 association with nephritis in Henoch-Schonlein purpura. J Rheumatol 2002; 29:948-949.
10. Ozdogan H, Arisoy N, KasapcapurO, et al. Vasculitis in familial Mediterranean fever. J Rheumatol 1997; 24:323-327.
11. Gershoni-Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schonlein purpura. J Pediatr 2003; 143:658-661.
12. Ozcakar ZB, Yalcinkaya F, Cakar N, et al. MEFV mutations modify the clinical presentation of Henoch-Schonlein purpura. J Rheumatol 2008;35:2427-2429.
13. Ben-Cherit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28:48-59.
14. Padeh S, Passwell JH. Successful treatment of chronic Henoch-Schonlein purpura with colchicine and aspirin. Isr Med Assoc J 2000; 2:482-483.
15. Saulsbury FT. Successful treatment of prolonged Henoch-Schonlein purpura with colchicine. Clin Pediatr 2009; 48:866-868.
16. Brogan PA. What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 2007; 22:1083-1094.
17. Yang YH, Chuang YH, Wang LC, et al. The immunobiology of Henoch-Schonlein purpura. Autoimmun Rev 2008; 7:179-184.
18. Saulsbury FT. Henoch-Schonlein purpura. Curr Opin Rheumatol 2001; 13:35-40.
19. Lau KK, Wyatt RJ, Moldoveanu Z, et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol 2007; 22:2067-2072. (Pubitemid 350090713)
20. Saulsbury FT. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schonlein purpura. J Rheumatol 1997; 24:2246-2249.
21. Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998; 13:930-934.
22. Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2010; 25:19-26.
23. Schmitt R, Carlsson F, Morgelin M, et al. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schonlein purpura. Am J Pathol 2010; 176:608-618.
24. 4 and leukotrienes in children with Henoch-Schonlein purpura. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009; 80:177-183.
25. Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 2006; 149:241-247.
26. Weiss PF, Klink AJ, Hexem K, et al. Variation in inpatient therapy and diagnostic evaluation of children with Henoch-Schonlein purpura. J Pediatr 2009; 155:812-818.
27. Dudley J, Smith G, Llewellyn-Edwards A, Tizard E. Randomised placebo controlled trial to assess the role of early prednisone on the development and progression of Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2007; 22:1457.
28. Huber AM, King J, McLain P, et al. A randomized, placebo-controlled trial of prednisone in early Henoch-Schonlein purpura. BMC Med 2004; 2:1-7.
29. Chartapisak W, Opastiraku S, Willis NS, et al. Prevention and treatment of renal disease in Henoch-Schonlein purpura: a systematic review. Arch Dis Child 2009; 94:132-137.
30. Zaffanello M, Fanos V. Treatment-based literature of Henoch-Schonlein purpura nephritis in childhood. Pediatr Nephrol 2009; 24:1901-1911.
31. Bogdanovic R. Henoch-Schonlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr 2009; 98:1882-1889.
32. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90:916-920.
33. Mir S, Yavascan O, Mutlubas F, et al. Clinical outcome in children with Henoch-Schonlein nephritis. Pediatr Nephrol 2007; 22:64-70.
34. Soylemezoglu O, Ozkaya O, Ozen S, et al. Henoch-Schonlein nephritis: a nationwide study. Nephron Clin Pract 2009; 112:199-204.
35. Halling SE, Soderberg MP, Berg UB. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis: a single center experience. Pediatr Nephrol 2009; 24:91-97.
36. Ronkainen J, Ala-Houhala M, Antikainen M, et al. Cyclosporine A (CSA) versus methylprednisolone pulses (MP) in the treatment of severe Henoch-Schö nlein purpura. Pediatr Nephrol 2006; 21:1531.
37. Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schön-lein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 2007; 22:1167-1171.
38. Donnithorne KJ, Atkinson TP, Hinze CH, et al. Rituximab therapy for severe refractory chronic Henoch-Schö nlein purpura. J Pediatr 2009; 155:136-139.